Booze calories nearly equal soda's for US adults

NEW YORK (AP) — Americans get too many calories from soda. But what about alcohol? It turns out adults get almost as many empty calories from booze as from soft drinks, a government study found.

Soda and other sweetened drinks — the focus of obesity-fighting public health campaigns — are the source of about 6 percent of the calories adults consume, on average. Alcoholic beverages account for about 5 percent, the new study found.

"We've been focusing on sugar-sweetened beverages. This is something new," said Cynthia Ogden, one of the study's authors. She's an epidemiologist with the Centers for Disease Control and Prevention which released its findings Thursday.

The government researchers say the findings deserve attention because, like soda, alcohol contains few nutrients but plenty of calories.

The study is based on interviews with more than 11,000 U.S. adults from 2007 through 2010. Participants were asked extensive questions about what they ate and drank over the previous 24 hours.

The study found:

—On any given day, about one-third of men and one-fifth of women consumed calories from beer, wine or liquor.

—Averaged out to all adults, the average guy drinks 150 calories from alcohol each day, or the equivalent of a can of Budweiser.

—The average woman drinks about 50 calories, or roughly half a glass of wine.

—Men drink mostly beer. For women, there was no clear favorite among alcoholic beverages.

—There was no racial or ethnic difference in average calories consumed from alcoholic beverages. But there was an age difference, with younger adults putting more of it away.

For reference, a 12-ounce can of regular Coca-Cola has 140 calories, slightly less than a same-sized can of regular Bud. A 5-ounce glass of wine is around 100 calories.

In September, New York City approved an unprecedented measure cracking down on giant sodas, those bigger than 16 ounces, or half a liter. It will take effect in March and bans sales of drinks that large at restaurants, cafeterias and concession stands.

Should New York officials now start cracking down on tall-boy beers and monster margaritas?

There are no plans for that, city health department officials said, adding in a statement that while studies show that sugary drinks are "a key driver of the obesity epidemic," alcohol is not.

Health officials should think about enacting policies to limit alcoholic intake, but New York's focus on sodas is appropriate, said Margo Wootan, director of nutrition policy for the Center for Science in the Public Interest, a public health advocacy group.

Soda and sweetened beverages are the bigger problem, especially when it comes to kids — the No. 1 source of calories in the U.S. diet, she said.

"In New York City, it was smart to start with sugary drinks. Let's see how it goes and then think about next steps," she said.

However, she lamented that the Obama administration is planning to exempt alcoholic beverages from proposed federal regulations requiring calorie labeling on restaurant menus.

It could set up a confusing scenario in which, say, a raspberry iced tea may have a calorie count listed, while an alcohol-laden Long Island Iced Tea — with more than four times as many calories — doesn't. "It could give people the wrong idea," she said.

___

Online:

CDC report: http://www.cdc.gov/nchs/

Read More..

Stock futures rise amid concerns over "fiscal cliff", Mideast

NEW YORK (Reuters) - Stock index futures edged higher on Thursday, suggesting equities might stage a rebound from a series of weak sessions.


Equities have had difficulty holding onto gains lately, as investors seek reasons to buy amid uncertainty over the "fiscal cliff" and unrest in the Middle East. Futures had also indicated gains Wednesday morning, but stocks turned lower midday and ended down more than 1 percent.


With Wednesday's decline, both the Dow industrials and the Nasdaq ended at their lowest levels since late June. The S&P 500 is down 5.1 percent in the six sessions since election night. Wednesday marked the benchmark index's lowest close since July 25.


Investors may seek bargains at these levels, and a round of economic data could prove to be a catalyst, but many analysts say strong gains may be hard to come by until at least one of the many global macroeconomic headwinds have been resolved.


S&P 500 futures rose 4.2 points and were above fair value, a formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract. Dow Jones industrial average futures added 20 points and Nasdaq 100 futures rose 7.75 points.


Wal-Mart Stores , Dell and Applied Materials are all scheduled to report quarterly results on Thursday.


Domestically, investors are looking at the fiscal cliff, a series of mandated tax hikes and spending cuts will start to take effect early next year that could push the U.S. economy into a recession.


President Obama Wednesday held to his position that marginal tax rates would have to rise to tackle the nation's deficits. Taxes on capital gains and dividends could rise as part of the negotiations, pushing investors to sell this year and pay lower taxes on their gains.


Overseas, Israel launched a major offensive against Palestinian militants in Gaza, killing the military commander of Hamas in an air strike and threatening an invasion of the enclave. Egypt said it recalled its ambassador from Israel in response.


The market will also watch the latest economic data, with weekly jobless claims, October consumer prices and a November read on New York manufacturing all due out at 8:30 a.m. (1330 GMT). The Philadelphia Federal Reserve Bank releases its November business activity survey at 10 a.m.


Claims are seen rising by 20,000 to 375,000 while consumer prices are seen up 0.1 percent, compared with a 0.6 percent rise in September, according to a Reuters poll. The Empire State manufacturing survey is seen coming in at -6.7, compared with -6.16 in October. The Philly Fed survey is seen dropping to 2 from 5.7 in October.


(Editing by W Simon)


Read More..

France recognizes new Syria opposition, U.S. restrained

BEIRUT (Reuters) - France became the first Western power to recognize a fledgling Syrian opposition coalition fully, stepping out beyond the United States, which said on Wednesday the body must first show its clout inside Syria.


Six Gulf Arab states recognized the Syrian National Coalition for Opposition and Revolutionary Forces on Monday and France followed suit the next day, unlike its European partners.


President Francois Hollande's decisive posture on Syria recalled that of his predecessor Nicolas Sarkozy on Libya last year, when France led calls for NATO action to protect civilians which effectively helped Libyan rebels topple Muammar Gaddafi.


The European Union bans arms sales to Syria, but Hollande said the question of arming rebels would be examined when the coalition formed a transitional government. Paris had previously ruled this out, fearing arms could reach Islamist militants.


U.S. Secretary of State Hillary Clinton said the formation of the coalition, which supersedes the widely discredited Syrian National Council as the face of the Syrian opposition, was an important step, but did not offer it full recognition or arms.


"We have long called for this kind of organization. We want to see that momentum maintained," Clinton told reporters in the Australian city of Perth. "As the Syrian opposition takes these steps and demonstrates its effectiveness in advancing the cause of a unified, democratic, pluralistic Syria, we will be prepared to work with them to deliver assistance to the Syrian people."


Suhair al-Atassi, a vice president of the new coalition, said that once it had proved it represents "revolutionary forces" on the ground, there would be no excuse for Western powers not to provide some form of military backing.


"The ball now is in the international community's court," she told Reuters in an interview in Dubai, blaming Western reticence to arm the rebels for the rise of extremism in Syria.


"There is no more excuse to say we are waiting to see how efficient this new body is. They used to put the opposition to the test. Now we put them to the test," she declared.


AIR STRIKE NEAR TURKEY


Syrian insurgents have few weapons against Assad's air force and artillery, which can pound rebel-held territory at will.


A Syrian warplane bombed the town of Ras al-Ain near the Turkish border again on Wednesday, rocking buildings on the frontier and sending up huge plumes of smoke, in the latest of several attacks since rebels captured the town last week.


After 20 months of a conflict that has killed more than 38,000 people, fragmented Syrian opposition groups struck a deal in Qatar on Sunday to form a coalition led by Damascus preacher Mouaz Alkhatib, who has appealed for international recognition.


Arab League and EU foreign ministers meeting in Cairo on Tuesday welcomed the coalition's formation as an important step, but did not recognize it as Syria's sole authority.


France, however, went ahead on its own. Hollande told a news conference in the French capital that Paris recognized the new Syrian national coalition "as the sole legitimate representative of the Syrian people and as future government of a democratic Syria making it possible to bring an end to Bashar al-Assad's regime".


Clinton announced an extra $30 million in aid to those affected by the war in Syria, to be delivered via the United Nations' World Food Programme, which is supplying food to more than a million people in Syria and to 408,000 Syrian refugees.


The United States says it is providing only humanitarian aid and non-lethal assistance to Assad's opponents, it acknowledges that some of its allies are arming rebels - something which Russia says shows Western powers want to decide Syria's future.


Russia and China have blocked any U.N. Security Council action on Syria, prompting Washington and its allies to say they could move beyond U.N. structures for their next steps.


So far, concerted action on Syria has been thwarted by divisions within the opposition, as well as by big power rivalries and a regional divide between Sunni Muslim foes of Assad and his Shi'ite allies in Iran and Lebanon.


An Iranian revolutionary guard general blamed Western, Turkish and Arab meddling for the bloodshed in Syria.


"They must leave the government and people of Syria alone so they can take the necessary decision about the kind of government in Syria," Brigadier-General Massoud Jazayeri was quoted as saying by the semi-official Fars news agency.


China also said Syrians should determine their own future.


"A political transition process guided by the Syrian people should be initiated and pushed forward as soon as possible, to realize an appropriate peaceful and just resolution," Foreign Ministry spokesman Hong Lei said.


(Additional reporting by John Irish in Paris, David Brunnstrom in Perth, Australia, Rania El Gamal in Dubai, Ben Blanchard in Beijing, Yasmine Saleh in Cairo and Jonathon Burch in Ceylanpinar, Turkey; Writing by Alistair Lyon; Editing by Jon Boyle)


Read More..

Software pioneer McAfee says framed for murder in Belize
















BELIZE CITY (Reuters) – Computer security industry pioneer John McAfee says he has gone into hiding in Belize because he believes authorities there are trying to frame him for the murder of a neighbor, a crime he says he did not commit, according to Wired magazine.


Belize police are searching for McAfee as “a person of interest” in a murder investigation.













“You can say I’m paranoid about it, but they will kill me, there is no question. They’ve been trying to get me for months. They want to silence me,” Wired quoted McAfee as saying on its website. “I am not well liked by the prime minister. I am just a thorn in everybody’s side.”


The magazine reported that McAfee, 67, contacted one of its reporters by telephone after his neighbor Gregory Faull, was found dead on Sunday in a pool of blood. The 52-year-old American was apparently shot in the head in his home on the island of Ambergris Caye.


Police say McAfee had a history of conflict with Faull, whose post-mortem was expected to be conducted on Tuesday.


McAfee, who amassed a fortune by building the anti-virus company that bears his name, has homes and businesses in the Central American country where police say he has lived for at least two years.


It was not the first time McAfee, who has tattoos, a goatee beard and mustache, and a penchant for guns, has drawn police attention in Belize.


His premises were raided earlier this year after he was accused of holding firearms, though most were found to be licensed. The final outcome of the case is pending.


He was also suspected of running a lab to make the synthetic drug crystal meth.


“He was suspected (of making crystal meth) but he was not convicted nor was he charged. He was only suspected,” said Belize police spokesman Raphael Martinez.


McAfee also owns a security company in Belize as well as several properties, an ecological enterprise and a water taxi and ferry business.


Reuters could not reach McAfee, who police want to question.


“It would be quite nice for him to come in and answer some of the questions that could lead to the closure of this case,” Martinez said. “He is not wanted for murder, but he is wanted for questioning as a person of interest.”


One man in Belize who knows McAfee well told Reuters he believed the American’s troubles began when he turned down requests for donations to the ruling United Democratic Party (UDP) to help fund its successful re-election bid in March.


“He rejected them because he doesn’t believe in participating in politics,” said the man, who spoke on condition of anonymity, calling McAfee an “honorable person.”


McAfee said earlier this year he had refused to donate to the UDP, which could not immediately be reached for comment.


The Belize police department has reached out to counterparts in neighboring Mexico and Guatemala, asking them to detain McAfee if he leaves Belize overland.


McAfee was one of Silicon Valley’s first entrepreneurs to amass a fortune by building a business off the Internet.


The former Lockheed systems consultant started McAfee Associates in 1989, initially distributing anti-virus software as “shareware” on Internet bulletin boards.


He took the company public in 1992 and left two years later following accusations that he had hyped the arrival of a virus known as Michelangelo, which turned out to be a dud, to scare computer users into buying his company’s products.


McAfee currently has no relationship with the software company, which has since been sold to Intel Corp.


(Reporting by Jim Finkle in Boston, Jose Sanchez in Belize City, Simon Gardner and Dave Graham in Mexico City; Editing by Kieran Murray and Eric Walsh)


Internet News Headlines – Yahoo! News



Read More..

The Voice Sends Two Contestants Home






The Voice










11/13/2012 at 10:20 PM EST







Adam Levine and Christina Aguilera


Christopher Polk/Getty


It was a great night for Teams Cee Lo and Adam on The Voice Tuesday. And though not everyone got good news on elimination night, there were plenty of entertaining performances from the coaches and contestants alike.

To open the night, Christina Aguilera and Green performed the world premiere of "Make the World Move," from her new album Lotus. Guest Jason Aldean also took the stage, and Blake Shelton rocked out with his team to Tom Cochrane's "Life is a Highway."

Green's Trevin Hunte, Nicholas David and Cody Belew came together for a '70s inspired – bell bottoms and all! – performance of the Bee Gee's "Stayin' Alive." But was it a sign of things to come? Keep reading for all the results ...

All of Green's singers as well as Levine's Bryan Keith, Melanie Martinez and Amanda Brown felt the love from viewers at home, and will have another shot at next week's show.

America also saved Aguilera's Sylvia Yacoub and Dez Duron, and Shelton's Cassadee Pope and Terry McDermott.

But without enough votes to keep them in the competition, Team Aguilera's Adriana Louise and Team Blake's Michaela Paige said goodbye.

Aguilera consoled Louise by reminding her that even she didn't win Star Search, but still made it to superstardom. Louise was grateful for all her coach's support. "You believed in me more than I believed in myself," she told Aguilera through tears.

Paige also enjoyed an uplifting experience on The Voice. "If I inspired anyone, that's all I wanted to do," Paige said. "Follow your dreams and believe in your heart." But her coach Shelton isn't too concerned about the aspiring singer's future.

"Her big old mohawk is going to be walking across the stage at the Grammys," he said, "and I can't wait."

Read More..

Report: FDA wanted to close Mass pharmacy in 2003

WASHINGTON (AP) — Nearly a decade ago, federal health inspectors wanted to shut down the pharmacy linked to a recent deadly meningitis outbreak until it cleaned up its operations, according to congressional investigators.

About 440 people have been sickened by contaminated steroid shots distributed by New England Compounding Center, and more than 32 deaths have been reported since the outbreak began in September, according to the Centers for Disease Control and Prevention. That has put the Framingham, Mass.-based pharmacy at the center of congressional scrutiny and calls for greater regulation of compounding pharmacies, which make individualized medications for patients and have long operated in a legal gray area between state and federal laws.

The House Energy and Commerce Committee released a detailed history of NECC's regulatory troubles on Monday, ahead of a meeting Wednesday meeting to examine how the outbreak could have been prevented. The 25-page report summarizes and quotes from FDA and state inspection memos, though the committee declined to release the original documents.

The report shows that after several problematic incidents, Food and Drug Administration officials in 2003 suggested that the compounding pharmacy be "prohibited from manufacturing" until it improved its operations. But FDA regulators deferred to their counterparts in Massachusetts, who ultimately reached an agreement with the pharmacy to settle concerns about the quality of its prescription injections.

The congressional report also shows that in 2003 the FDA considered the company a pharmacy. That's significant because in recent weeks public health officials have charged that NECC was operating more as a manufacturer than a pharmacy, shipping thousands of doses of drugs to all 50 states instead of small batches of drugs to individual patients. Manufacturers are regulated by the FDA and are subject to stricter quality standards than pharmacies.

The report offers the most detailed account yet of the numerous regulatory complaints against the pharmacy, which nearly date back to its founding in 1998. Less than a year later, the company was cited by the state pharmacy board for providing doctors with blank prescription pads with NECC's information. Such promotional items are illegal in Massachusetts and the pharmacy's owner and director, Barry Cadden, received an informal reprimand, according to documents summarized by the committee.

Cadden was subject to several other complaints involving unprofessional conduct in coming years, but first came to the FDA's attention in 2002. Here are some key events from the report highlighting the company's early troubles with state and federal authorities:

__ In March of 2002 the FDA began investigating reports that five patients had become dizzy and short of breath after receiving NECC's compounded betamethasone repository injection, a steroid used to treat joint pain and arthritis that's different from the one linked to the current meningitis outbreak.

FDA inspectors visited NECC on April 9 and said Cadden was initially cooperative in turning over records about production of the drug. But during a second day of inspections, Cadden told officials "that he was no longer willing to provide us with any additional records," according to an FDA report cited by congressional investigators. The inspectors ultimately issued a report citing NECC for poor sterility and record-keeping practices but said that "this FDA investigation could not proceed to any definitive resolution," because of "problems/barriers that were encountered throughout the inspection."

__ In October of 2002, the FDA received new reports that two patients at a Rochester, N.Y., hospital came down with symptoms of bacterial meningitis after receiving a different NECC injection. The steroid, methylprednisolone acetate, is the same injectable linked to the current outbreak and is typically is used to treat back pain. Both patients were treated with antibiotics and eventually recovered, according to FDA documents cited by the committee.

When officials from the FDA and Massachusetts Board of Pharmacy visited NECC later in the month, Cadden said vials of the steroid returned by the hospital had tested negative for bacterial contamination. But when FDA scientists tested samples of the drug collected in New York they found bacterial contamination in four out of 14 vials sampled. It is not entirely clear whether FDA tested the same lot shipped to the Rochester hospital.

__ At a February 2003 meeting between state and federal officials, FDA staff emphasized "the potential for serious public consequences if NECC's compounding practices, in particular those relating to sterile products, are not improved." The agency issued a list of problems uncovered in its inspection to NECC, including a failure to verify if sterile drugs met safety standards.

But the agency decided to let Massachusetts officials take the lead in regulating the company, since pharmacies are typically regulated at the state level. It was decided that "the state would be in a better position to gain compliance or take regulatory action against NECC as necessary," according to a summary of the meeting quoted by investigators.

The FDA recommended the state subject NECC to a consent agreement, which would require the company to pass certain quality tests to continue operating. But congressional investigators say Massachusetts Board of Pharmacy did not take any action until "well over a year later."

__ In October 2004, the board sent a proposed consent agreement to Cadden, which would have included a formal reprimand and a three-year probationary period for the company's registration. The case ended without disciplinary action in 2006, when NECC agreed to a less severe consent decree with the state.

Massachusetts officials indicated Tuesday they are still investigating why NECC escaped the more severe penalty.

"I will not be satisfied until we know the full story behind this decision," the state's interim health commissioner Lauren Smith said in a transcript of her prepared testimony released a day ahead of delivery. Smith is one of several witnesses scheduled to testify Wednesday, including FDA Commissioner Margaret Hamburg.

The committee will also hear from the widow of 78-year-old Eddie C. Lovelace, a longtime circuit court judge in southern Kentucky. Autopsy results confirmed Lovelace received fungus-contaminated steroid injections that led to his death Sept. 17.

Joyce Lovelace will urge lawmakers to work together on legislation to stop future outbreaks caused by compounded drugs, according to a draft of her testimony.

"We now know that New England Compounding Pharmacy, Inc. killed Eddie. I have lost my soulmate and life's partner with whom I worked side by side, day after day for more than fifty years," Lovelace states.

Barry Cadden is also scheduled to appear at the hearing, after lawmakers issued a subpoena to compel him to attend.

The NECC has been closed since early last month, and Massachusetts officials have taken steps to permanently revoke its license. The pharmacy has recalled all the products it makes, including 17,700 single-dose vials of a steroid that tested positive for the fungus tied to the outbreak.

Read More..

Stock futures rise, helped by Cisco results

NEW YORK (Reuters) - Stock index futures rose on Wednesday, indicating that equities would rebound after a series of weak sessions on strong results from Cisco.


The S&P 500 has fallen 3.8 percent over the past five session, with most of those losses driven by uncertainty over looming U.S. "fiscal cliff" demand and persisting concerns over Europe. The index closed below its 200-day moving average for a fourth day in a row on Tuesday, a technical indicator that suggests recent declines could gain momentum.


Cisco Systems Inc reported first-quarter earnings and revenue late Tuesday that beat expectations, sending the stock soaring 8.3 percent to $18.25 in premarket trading Wednesday. The Dow component also forecast flat earnings and slower revenue growth for the current quarter.


The results could boost sentiment over the technology sector <.gspt>, where shares have dropped almost 10 percent in value over the past two months, dragged down by earnings disappointments from key names like Google . Tech was the worst-performing sector on Tuesday.


Still, macroeconomic issues will likely still play a major role in trading direction as investors continue to grapple with Europe's debt crisis and the fiscal cliff, a series of mandated tax hikes and spending cuts that start to take effect next year.


Analysts say serious fiscal negotiations are still weeks away, but that the failure to reach a deal in Congress could tip the world's largest economy into recession.


S&P 500 futures rose 6.7 points and were above fair value, a formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract. Dow Jones industrial average futures added 48 points and Nasdaq 100 futures rose 17.5 points.


European shares <.fteu3> were 0.5 percent lower as Greece's unresolved debt crisis continued to raise questions about the region's growth potential, while anti-austerity strikes across southern Europe added to concerns that measures to deal with the debt would be politically difficult to implement.


International Monetary Fund Managing Director Christine Lagarde said on Wednesday she expected a real fix for Greece that included debt sustainability, rather than a quick fix.


Tyco reported adjusted fourth-quarter earnings that missed expectations. NetApp Inc , Staples Inc and Abercrombie & Fitch are on tap to report later Wednesday.


October retail sales are on tap for release at 8:30 a.m. ET (1330 GMT) and are seen dropping 0.2 percent. In September, sales climbed 1.1 percent. Also, the latest FOMC minutes will be released Wednesday afternoon.


U.S. stocks fell in a volatile session Tuesday, pressured by Microsoft Corp which fell after the surprise departure of a key executive. However, retail names outperformed after Home Depot raised its outlook.


(Editing by Bernadette Baum)


Read More..

Syrian opposition faces uphill battle for recognition

CAIRO (Reuters) - Syria's new opposition body sought Arab and European backing on Tuesday, but Britain and France seemed to set new conditions for its recognition as an interim government to take over should President Bashar al-Assad fall.


The Syrian leader has vowed to fight to the death in a conflict that has already killed an estimated 38,000 people and risks sucking in other countries in the volatile Middle East.


Arab and European officials met leaders of the new Syrian National Coalition in Cairo in Tuesday as Assad's warplanes again struck homes in the northern, rebel-held town of Ras al-Ain. Civilians fled over the border dividing it from the Turkish town of Ceylanpinar and thick plumes of smoke billowed upwards.


Syrian jets and artillery hit the town of Albu Kamal on the frontier with Iraq, where rebels have seized some areas, according to the mayor of the Iraqi border town of Qaim.


Tension also remained high on the Golan Heights, where Israeli gunners have retaliated against stray Syrian mortar fire landing on the occupied plateau in the previous two days.


Twenty months of conflict have created a vast humanitarian crisis, with more than 408,000 Syrians fleeing to neighboring countries and up to four million expected to need aid by early next year, according to the United Nations.


Fighting has also displaced 2.5 million civilians inside Syria, the Syrian Arab Red Crescent estimates.


"If anything, they believe it could be more; this is a very conservative estimate," Melissa Fleming, chief spokeswoman of the U.N. High Commissioner for Refugees, said in Geneva.


"So people are moving, really on the run, hiding," she told a news briefing. "They are difficult to count and access."


FRAGMENTED RESPONSE


Until now, concerted action on Syria has been thwarted by divisions within the opposition, as well as by big power rivalries and a regional divide between Sunni Muslim foes of Assad and his Shi'ite allies in Iran and Lebanon.


Cajoled by Qatar and the United States, the ineffectual Syrian National Council, previously the main opposition body based abroad, agreed to join a wider coalition on Sunday.


But France's defense minister said it was premature to give the new body full recognition, saying it needed to unite armed rebel factions within Syria under its umbrella.


"What happened in Doha is a step forward," Jean-Yves Le Drian told reporters in Paris. "It is still not sufficient to constitute a provisional government that can be recognized internationally. But it's on the right track."


Britain's foreign minister, William Hague, also said more needed to be done to rally support inside the country before London would recognize the coalition led by moderate Muslim cleric Mouaz Alkhatib as the rightful government of Syria.


"It is a very important milestone," Hague told reporters at a meeting of Arab and European ministers at the Arab League headquarters in Cairo.


"We want to see the Syrian opposition be inclusive ... and have support inside Syria and if they have this, yes, we will then recognize them as the legitimate representative of the Syrian people."


The opposition had hoped its new-found unity would clear the way for outside powers to arm the rebels, but Western nations fear such weapons could reach the hands of Islamist militants.


Western concern has also been heightened by documented reports of atrocities by ill-disciplined insurgents.


"Syria's newly created opposition front should send a clear message to opposition fighters that they must adhere to the laws of war and human rights law, and that violators will be held accountable," New York-based Human Rights Watch said.


The French defense minister called for "a unification of military action to avoid haphazard military operations" and also urged rebels to rein in radical Islamist "Salafist elements".


TOUGH QUEST


European caution, and an Arab League endorsement that stops well short of full recognition, indicate that the coalition forged with such difficulty in Qatar two days ago may face a tough quest for wholehearted backing, even from its allies.


Russia and China, which have lent Assad diplomatic support since the uprising erupted in March last year, have shown no sign of warming towards his Western- and Arab-backed opponents.


Arab League chief Nabil Elaraby threw his weight behind the new body at the Arab-European meeting in Cairo.


"We hope that the remaining opposition factions join the Syrian National Coalition for Opposition and Revolutionary Forces and we urge the countries of the world to recognize it and give it all the support," he said.


But although six Gulf Arab nations recognized the coalition as Syria's only legitimate representative on Monday, Iraq, Algeria and Lebanon prevented the League from following suit. Iraq and Lebanon, with influential Shi'ite populations, have generally maintained better relations with Iran and with Assad.


In other scattered violence reported by opposition activists inside Syria, the governor Raqqa province in the northeast wounded in an attack on his convoy, the Syrian Observatory for Human Rights said. In the same province, a bomb near a church killed a woman, state news agency SANA said, blaming rebels.


Near Damascus, the rebel unit the Armored Ghouta Brigade said in an online video posting showing smoke and damage at a military installation that its fighters had stormed an air defense base and "killed many officers".


None of the reports of violence in Syria could be independently confirmed.


(Additional reporting by Shaimaa Fayed in Cairo, Jonathon Burch in Ceylanpinar, Turkey and John Irish in Paris; Writing by Alistair Lyon; Editing by Alastair Macdonald)


Read More..

See Keira Knightley's Prettiest Anna Karenina Costumes







Style News Now





11/12/2012 at 05:30 PM ET











Keira Knightley in Anna Karenina
Courtesy Focus Features


We’re so excited to see Anna Karenina this weekend, not only because we loved the book, but because we can’t wait to see Keira Knightley‘s costumes.


Designed by Oscar nominee Jacqueline Durran, the elaborate gowns and structured uniforms required lots of blood, sweat and tears — but it was all worth it.


“Period films are absolutely a challenge because you never have enough time,” Durran tells PEOPLE. “You’re always racing to try and catch up.” However, working with Knightley and director Joe Wright — both of whom she collaborated with on Pride & Prejudice and Atonement — made the process much easier.


“It’s very hard work, and very last-minute, but with them, it’s a pleasure,” Durran says. “It’s just much easier to work with people you like and know.”


It’s also easier to work with an actress like Knightley, who looks gorgeous in everything. Durran dressed her in gowns that were “1870s silhouette meets 1950s couture” — and are absolutely stunning. To see some of our favorites, click through these photos. And see all of Durran’s work come to life when Anna Karenina hits theaters Friday. Tell us: Are you planning to see Anna Karenina this weekend? 


–Kate Hogan


PHOTOS: KEIRA IN COSTUME! SEE EXCLUSIVE ‘ANNA KARENINA’ SHOTS




Read More..

British medical journal slams Roche on Tamiflu

LONDON (AP) — A leading British medical journal is asking the drug maker Roche to release all its data on Tamiflu, claiming there is no evidence the drug can actually stop the flu.

The drug has been stockpiled by dozens of governments worldwide in case of a global flu outbreak and was widely used during the 2009 swine flu pandemic.

On Monday, one of the researchers linked to the BMJ journal called for European governments to sue Roche.

"I suggest we boycott Roche's products until they publish missing Tamiflu data," wrote Peter Gotzsche, leader of the Nordic Cochrane Centre in Copenhagen. He said governments should take legal action against Roche to get the money back that was "needlessly" spent on stockpiling Tamiflu.

Last year, Tamiflu was included in a list of "essential medicines" by the World Health Organization, a list that often prompts governments or donor agencies to buy the drug.

Tamiflu is used to treat both seasonal flu and new flu viruses like bird flu or swine flu. WHO spokesman Gregory Hartl said the agency had enough proof to warrant its use for unusual influenza viruses, like bird flu.

"We do have substantive evidence it can stop or hinder progression to severe disease like pneumonia," he said.

In the U.S., the Centers for Disease Control and Prevention recommends Tamiflu as one of two medications for treating regular flu. The other is GlaxoSmithKline's Relenza. The CDC says such antivirals can shorten the duration of symptoms and reduce the risk of complications and hospitalization.

In 2009, the BMJ and researchers at the Nordic Cochrane Centre asked Roche to make all its Tamiflu data available. At the time, Cochrane Centre scientists were commissioned by Britain to evaluate flu drugs. They found no proof that Tamiflu reduced the number of complications in people with influenza.

"Despite a public promise to release (internal company reports) for each (Tamiflu) trial...Roche has stonewalled," BMJ editor Fiona Godlee wrote in an editorial last month.

In a statement, Roche said it had complied with all legal requirements on publishing data and provided Gotzsche and his colleagues with 3,200 pages of information to answer their questions.

"Roche has made full clinical study data ... available to national health authorities according to their various requirements, so they can conduct their own analyses," the company said.

Roche says it doesn't usually release patient-level data available due to legal or confidentiality constraints. It said it did not provide the requested data to the scientists because they refused to sign a confidentiality agreement.

Roche is also being investigated by the European Medicines Agency for not properly reporting side effects, including possible deaths, for 19 drugs including Tamiflu that were used in about 80,000 patients in the U.S.

____

Online:

www.bmj.com.tamiflu/

Read More..